Episode

HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Podcast
Breast Cancer Update
Published
Jan 14, 2026
Duration seconds
7098
Processing state
not_requested
Canonical source
https://breast-oncology.captivate.fm/episode/5623-sanantonioher2posbc25
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/ee737d96-df10-4104-97ed-265e0213c607.mp3
JSON
/v1/public/podcasts/breast-cancer-update-757579/episodes/her2-positive-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series
Markdown
/podcast/breast-cancer-update-757579/her2-positive-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/her2-positive-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/breast-cancer-update-757579/her2-positive-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Prof Giuseppe Curigliano from the University of Milan in Italy, Prof Nadia Harbeck from LMU University Hospital in Munich, Germany, Dr Ian E Krop from Yale Cancer Center, Dr Nancy U Lin from Dana-Farber Cancer Institute and Dr Joyce O’Shaughnessy from Baylor University Medical Center discuss real-world cases and recent clinical data pertinent to the management of HER2-positive breast cancer. CME information and select publications here .